共 19 条
[1]
Pardanani A(2006)Pathogenesis, clinical features, and treatment advances in mastocytosis Best Pract Res Clin Haematol 19 595-615
[2]
Akin C(2001)Histological characteristics and prevalence of secondary osteoporosis in systemic mastocytosis, A retrospective analysis of 158 cases Pathologe 22 132-140
[3]
Valent P(2006)The role of mast cells in osteoporosis Semin Arthritis Rheum 36 32-36
[4]
Delling G(1997)H1 and H2 histamine receptors modulate osteoclastic resorption by different pathways: evidence obtained by using receptor antagonists in a rat synchronized resorption model J Cell Physiol 173 10-18
[5]
Ritzel H(2008)Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis Clin Cancer Res 14 3906-3915
[6]
Werner M(2005)Systemic mastocytosis: a rare cause of osteoporosis and its response to bisphosphonate treatment Ann Rheum Dis 64 965-966
[7]
Chiappetta N(1996)Severe osteoporosis due to systemic mast cell disease: successful treatment with Interferon alpha 2B Br J Rheumatol 35 898-900
[8]
Gruber B(undefined)undefined undefined undefined undefined-undefined
[9]
Dobigny C(undefined)undefined undefined undefined undefined-undefined
[10]
Saffar JL(undefined)undefined undefined undefined undefined-undefined